Breaking News
March 24, 2018 - Morning Break: Skip the Finger Exam? Self C-Section; Toxic Toenail Fungus
March 24, 2018 - 3-D simulations reveal synergistic mechanisms of the human heart
March 24, 2018 - Newly designed three-part molecule shows promise to treat breast cancers
March 24, 2018 - Pubertal hormones not responsible for changes in social behavior during adolescence
March 24, 2018 - Waning Vaccine Protection May Be Driving Rise in U.S. Mumps Cases
March 24, 2018 - Folic Acid in Utero Tied to Food Allergy Risk
March 24, 2018 - Trial shows safety of drugs for irregular heartbeat patients undergoing treatment
March 24, 2018 - Penn State psychologists shed light on false memories in older adults
March 24, 2018 - Patients who self-discharge should be viewed more positively, say researchers
March 24, 2018 - Wearable brain scanner enables brain imaging whilst moving
March 24, 2018 - Trump Signs $1.3 Trillion Spending Bill, Averts Shutdown
March 24, 2018 - Two drugs prevent heart problems in breast cancer patients
March 24, 2018 - Research provides better understanding of how some cancer cells resist treatment
March 24, 2018 - Certain nutrients found in food may help reduce symptoms of psychotic illness
March 24, 2018 - AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
March 24, 2018 - AHRQ Is in Trouble | Medpage Today
March 24, 2018 - Could a pap test spot more than just cervical cancer?
March 24, 2018 - Men have greater hospital readmission risk following firearm injury, study shows
March 24, 2018 - Pediatric psychologist shares 11 warning signs of childhood depression
March 24, 2018 - OncoBreak: ‘I Was Normal Once’; Ending Cervical Cancer; Mammo Controversy
March 24, 2018 - Gum Disease by the Numbers
March 24, 2018 - Studies show tool can identify individual needs, supports to help youths with autism, intellectual disabilities
March 24, 2018 - Study reveals cause of extreme nausea in pregnancy
March 24, 2018 - New findings highlight need to reconsider cervical cancer screening guidelines
March 24, 2018 - Smartwatch App Might Help Detect A-Fib
March 24, 2018 - TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis
March 24, 2018 - Kids with severe brain injuries may develop ADHD: study
March 24, 2018 - Researchers explore ways to help older adults taper off and stop using sedatives
March 24, 2018 - Back pain being mismanaged globally
March 24, 2018 - Fingerprint test accurately and noninvasively detects heroin, cocaine users
March 24, 2018 - Leading experts to promote cardiovascular health at EuroPrevent 2018
March 24, 2018 - A Role for Rituximab in Lupus?
March 24, 2018 - New osteoarthritis genes discovered
March 24, 2018 - Maternal intake of DHA supplement linked to higher fat-free body mass in children
March 24, 2018 - Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop
March 24, 2018 - Maternal alcohol use early in pregnancy may be risk factor for infant abdominal malformation
March 24, 2018 - Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
March 24, 2018 - Accelerated WBI Should be the Norm for Most Breast Cancers
March 24, 2018 - Experts seek to standardize treatments for childhood rheumatic diseases
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Researchers identify chemical responsible for carcinogen formation in recycled wastewater
March 24, 2018 - Obesity and severe obesity continue to rise among U.S. adults
March 24, 2018 - Missed hospital appointments increase after spring clock change in the UK
March 24, 2018 - Researchers explore ways to manage and prevent falls in older adults with dementia
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - NUST MISIS researchers produce elastic metal rods for scoliosis treatment
March 24, 2018 - New University of Bath project seeks to make injections safer
March 24, 2018 - Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
March 23, 2018 - Researchers identify potential obesity treatment in freezing hunger-signaling nerve
March 23, 2018 - Wales participates in the 100,000 Genomes Project
March 23, 2018 - 24-Hr Paging Cuts ED Visits for Kids with Endocrine Issues
March 23, 2018 - The brain learns completely differently than we’ve assumed since the 20th century
March 23, 2018 - Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians
RA Biomarker Panel IDs Patients at High Risk for Cardiovascular Events

RA Biomarker Panel IDs Patients at High Risk for Cardiovascular Events

image_pdfDownload PDFimage_print

Action Points

  • Higher rheumatoid arthritis (RA) disease activity, as measured by a multi-biomarker disease activity (MBDA) panel of biomarkers, was associated with higher rates of hospitalized infections, myocardial infarction (MI), and coronary heart disease (CHD) events.
  • The 100-point MBDA system, based on a set of 12 protein biomarkers, has been shown to correlate well with disease activity in several RA cohorts, and is commercially available from Crescendo Biosciences under the name Vectra DA.

Higher rheumatoid arthritis (RA) disease activity, as measured by a multi-biomarker disease activity (MBDA) panel, was associated with higher rates of hospitalized infections, myocardial infarction (MI), and coronary heart disease (CHD) events, analysis of Medicare data indicated.

Higher MBDA test scores were associated with increased serious infection events (HR 1.32 per 10-unit score increment, 95% CI 1.23-1.41), Jeffrey R. Curtis, MD, MPH, of the University of Alabama at Birmingham and colleagues reported.

Scores higher than 30 also were associated with increased MI (HR 1.52, 95% CI 0.92-2.49) and CHD rates (HR 1.54, 95% CI 1.01-2.34), compared with scores less than 30.

“In this large RA population predominantly consisting of older individuals, higher MBDA scores were associated with increased risk for hospitalized infection, MI and CHD events,” they wrote in Annals of the Rheumatic Diseases.

“A strong dose–response gradient existed between MBDA scores and hospitalized infections (pneumonia and sepsis). The patterns for MI and CHD events suggested more of a threshold effect, where those with the lowest level of disease activity and inflammation were at lowest risk, but gradations with higher levels of the biomarker were relatively absent,” they added.

The 100-point MBDA system is based on a set of 12 protein biomarkers, shown to correlate well with disease activity in several RA cohorts. It is commercially available from Crescendo Biosciences under the name Vectra DA. A score under 30 is considered low, 30–44 moderate, and over 44 high.

For this analysis, the researchers used national Medicare fee-for-service claims from 2010 to 2014, linking that information to patient-specific MBDA scores supplied by Crescendo.

To be included in the study, a patient needed to have at least one valid MBDA score linked to Medicare claims and at least 365 continuous days of Medicare with Part D coverage before the first valid MBDA test date.

The researchers excluded patients who had an International Classification of Diseases (ICD)-9 diagnosis code for ankylosing spondylitis, inflammatory bowel disease psoriasis, psoriatic arthritis, systemic lupus erythematosus, malignancy (except non-melanoma skin cancer), polymyalgia rheumatica, and giant cell arteritis in the 12-month baseline period. They also excluded patients who had initiated any non-tumor necrosis factor biologic or synthetic targeted disease-modifying anti-rheumatic drugs (DMARDs) in the 183 days before the index date.

Patients who had a prior MI, coronary artery bypass grafting, or percutaneous coronary intervention were not included in the MI and CHD outcome.

Because MBDA scores could be affected by an evolving outpatient infection or MI, the researchers also excluded patients from the MI and CHD analysis if they had heart attacks or coronary events in the 7 days following the MBDA test. Similarly, they excluded patients from the serious infection outcome if they had a serious infection in the 14 days after the test.

A total of 17,433 patients were eligible for the serious infection analysis and 16,796 patients for the MI and CHD outcome. Overall, the average age was 69 years; 79% were women, 81% were white, and 38% were disabled. These patients used methotrexate (54%), oral glucocorticoids (53%), non-biologic DMARDs (40%) and biologics (17%) to treat their RA.

Characteristics of patients in lower MBDA categories suggested they were younger (a 3-year difference), had a lower burden of comorbidities, and used less glucocorticoids and more biologics than patients with higher MBDA scores.

After multivariable adjustment, higher MBDA scores were associated with statistically significantly higher rates of serious infection events and higher MI and CHD rates.

Because C-reactive protein, one of the MBDA biomarkers, might influence outcomes, the researchers performed sensitivity analyses excluding it and found similar results: a 1.5-fold (CHD) and 1.7-fold (MI) elevated risk for patients in the higher disease activity category compared with the lowest.

“The current study is novel in that it leveraged a large administrative data source linked to a laboratory test provider database to address a question that neither data source by itself could address,” the authors wrote.

The results should be interpreted in light of the study design, they noted. It included predominantly older adults and findings might not apply to younger RA patients.

“However, given that the prevalence of infectious and CHD risk factors generally increases with age, we would speculate that the associations between RA disease activity and the outcomes that we studied might be even stronger in younger patients with RA,” they wrote.

This analysis was supported in part by Crescendo Bioscience, which is part of Myriad Genetics.

Curtis is a consultant for Myriad Genetics and has received research grants from them.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner


last updated

Tagged with:

About author

Related Articles